H

Hangzhou Biotest Biotech Co Ltd
SSE:688767

Watchlist Manager
Hangzhou Biotest Biotech Co Ltd
SSE:688767
Watchlist
Price: 37.78 CNY -3.08% Market Closed
Market Cap: 5.6B CNY

Wall Street
Price Targets

Price Targets Summary
Hangzhou Biotest Biotech Co Ltd

There are no price targets for Hangzhou Biotest Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hangzhou Biotest Biotech Co Ltd Competitors:
Price Targets
SLS
Sellas Life Sciences Group Inc
111% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
66% Upside
IONS
Ionis Pharmaceuticals Inc
9% Upside
214450
PharmaResearch Co Ltd
94% Upside
TGTX
TG Therapeutics Inc
50% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
9% Upside
CYTK
Cytokinetics Inc
36% Upside
SNDX
Syndax Pharmaceuticals Inc
88% Upside

Revenue
Forecast

Revenue Estimate
Hangzhou Biotest Biotech Co Ltd

For the last 5 years the compound annual growth rate for Hangzhou Biotest Biotech Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is 17%.

22%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hangzhou Biotest Biotech Co Ltd

Operating Income forecast
is not available for
Hangzhou Biotest Biotech Co Ltd

Net Income
Forecast

Net Income Estimate
Hangzhou Biotest Biotech Co Ltd

For the last 5 years the compound annual growth rate for Hangzhou Biotest Biotech Co Ltd's net income is 43%. The projected CAGR for the next 3 years is 9%.

43%
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hangzhou Biotest Biotech Co Ltd's stock price target?
Not Available

Hangzhou Biotest Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Hangzhou Biotest Biotech Co Ltd's Revenue forecast?
Projected CAGR
17%

For the last 5 years the compound annual growth rate for Hangzhou Biotest Biotech Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is 17%.

What is Hangzhou Biotest Biotech Co Ltd's Net Income forecast?
Projected CAGR
9%

For the last 5 years the compound annual growth rate for Hangzhou Biotest Biotech Co Ltd's net income is 43%. The projected CAGR for the next 3 years is 9%.

Back to Top